Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Improving Function While Maintaining Oncologic...

Area of Science:

• Oncology
• Head and Neck Surgery
• Viral Oncology

Background:

• Improved survival rates in HPV-positive oropharyngeal squamous cell carcinoma (OPSCC) compared to HPV-negative OPSCC.
• The need for treatment strategies that prioritize functional outcomes, such as swallowing, alongside oncologic control.

Purpose of the Study:

• To summarize current clinical trials investigating treatment de-escalation for HPV-positive OPSCC.
• To highlight the challenges in managing this evolving disease cohort.

Main Methods:

• Review of ongoing clinical trials focusing on transoral robotic surgery (TORS), reduced-dose radiotherapy, and chemotherapy omission.
• Discussion of treatment algorithm changes and management challenges.

Main Results:

• Multiple trials are assessing less invasive surgical options (TORS) and reduced treatment intensity (radiotherapy, chemotherapy).
• The focus is on balancing efficacy with improved quality of life for patients with HPV-positive OPSCC.

Conclusions:

• Treatment de-escalation is a key area of research for HPV-positive OPSCC.
• Head and neck oncology surgeons must stay informed about evolving treatment paradigms and consider patient enrollment in clinical trials.